Histamine has been shown to play an important role in immune cell function (Hansson et al., 1999), and a histamine/IL‐2 combination has been used to increase T‐cell responses in stage IV melanoma patients (Asemissen et al., 2005). This evidence concerns the gene IL2 and melanoma.